Beta Bionics, Inc. (BBNX) stock
Close on Nov 13, 2026Market cap $892.71MP/E –Yield –
Beta Bionics, Inc. grew revenue 43.7% to $127.27M over the twelve months to Sep 30, 2026. Free cash flow was -$65.96M. At the latest close the market valued the company at $892.71M.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Sep 30, 2026
Valuation
- Market cap
- $892.71M
- P/E ratio
- –
- Price to sales
- 7.01
- Price to book
- 2.22
- Dividend yield
- –
- Free cash flow yield
- -7.39%
Fundamentals
- Revenue
- $127.27M
- Net income
- -$83.12M
- EPS, diluted
- -$1.84
- Free cash flow
- -$65.96M
- Book value per share
- $8.62
- Diluted shares
- 47M
Trading
- Next earnings
- Feb 16, 2027 (estimated, after the close)
- Previous close
- $16.51
- Open
- $16.57
- Day's range
- $16.09 – $17.53
- Volume
- 1,095,378
- Average volume (20 days)
- 1,192,810
- Index membership
- Russell 2000 (since Mar 2025), Russell 3000 (since Aug 2025)
- 52-week range
- $8.80 – $32.71
- RSI (14 days)
- 45.5
- Volatility (1 year)
- 84.8%
- Relative volume
- 0.88×
Index membership is inferred from the holdings of funds that track each index (IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 13, 2026. The S&P 500 is measured by the SPY fund.
| Period | BBNX | S&P 500 | Difference | BBNX per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -7.2% | -3.0% | −4.1 pts | ||
| 3 months | -9.2% | -2.8% | −6.4 pts | ||
| Year to date | -46.1% | +11.5% | −57.6 pts | ||
| 1 year | -37.4% | +13.5% | −50.9 pts |
Four years at a glance
Fiscal years 2022 to 2025 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Beta Bionics filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- News
- News
- Update
- Update
- Results
About Beta Bionics
Surgical & Medical Instruments & Apparatus
Beta Bionics, Inc. is a medical technology company that develops and commercializes automated insulin delivery solutions for diabetes management. The company's primary commercial offering is the iLet, an automated insulin dosing system, alongside related single-use products and components. Its technology is designed for patients with type 1 diabetes, specifically cleared for adults and children aged six and older. The company distributes its medical devices and supplies to patients through healthcare channels, including durable medical equipment providers and pharmacy benefit plans.
Company profile, executives and historyBeta Bionics stock: common questions
What is Beta Bionics's stock price?
BBNX closed at $16.42 on Nov 13, 2026, down 0.55% on the day. Over the past 52 weeks it traded between $8.80 and $32.71.
What is Beta Bionics's market cap?
Beta Bionics was worth $892.71M at the close on Nov 13, 2026: the share price times the diluted shares outstanding.
What is BBNX's P/E ratio?
Beta Bionics lost money over the twelve months to Sep 30, 2026 (diluted EPS -$1.84), so it has no meaningful P/E ratio.
How much revenue does Beta Bionics make?
Beta Bionics reported revenue of $127.27M for the twelve months to Sep 30, 2026, up 43.7% from a year earlier.
Does Beta Bionics pay a dividend?
No. Beta Bionics has not paid a cash dividend over the last twelve months.
When does Beta Bionics report earnings next?
Beta Bionics is expected to report Q4 FY2026 results on Feb 16, 2027, after the close. The date is estimated from its past reporting pattern until the company confirms it.
How has BBNX stock performed over the past year?
Including dividends, BBNX returned -37.4% over the past year, against +13.5% for the S&P 500.
How many BBNX shares are sold short?
5M shares were sold short at the latest FINRA report, 10.10% of the float, or 3.9 days of average trading volume.
Who are Beta Bionics's competitors?
Companies most similar to Beta Bionics by business, industry and size include KMTS, PDEX, RCEL, INFU, ANIK.
See a number that looks wrong?